“Design, Synthesis, and In-Silico Evaluation of Benzyl Oxybenzoate Derivatives As Dual HDAC Inhibitors for Cancer and CNS Disorders”. 2026. Al Mustansiriyah Journal of Pharmaceutical Sciences 25 (5): 917-30. https://doi.org/10.32947/ajps.v25i5.1307.